NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications.
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications.
复制标题
NF-κB通路在多发性硬化发病机制中的作用及其治疗意义。
DOI:
10.3389/fnmol.2016.00084
复制
发表时间:
2016
影响因子:
4.8
通讯作者:
Yan J
中科院分区:
文献类型:
--
作者:
Leibowitz SM;Yan J
Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathways are involved in cell immune responses, apoptosis and infections. In multiple sclerosis (MS), NF-κB pathways are changed, leading to increased levels of NF-κB activation in cells. This may indicate a key role for NF-κB in MS pathogenesis. NF-κB signaling is complex, with many elements involved in its activation and regulation. Interestingly, current MS treatments are found to be directly or indirectly linked to NF-κB pathways and act to adjust the innate and adaptive immune system in patients. In this review, we will first focus on the intricacies of NF-κB signaling, including the activating pathways and regulatory elements. Next, we will theorize about the role of NF-κB in MS pathogenesis, based on current research findings, and discuss some of the associated therapeutic implications. Lastly, we will review four new MS treatments which interrupt NF-κB pathways—fingolimod, teriflunomide, dimethyl fumarate (DMF) and laquinimod (LAQ)—and explain their mechanisms, and the possible strategy for MS treatments in the future.
登录
查看更多内容
影响因子:
64.8
作者:
Belich, MP;Salmerón, A;Ley, SC
通讯作者:
Ley, SC
影响因子:
158.5
作者:
Comi, Giancarlo;Jeffery, Douglas;Filippi, Massimo
通讯作者:
Filippi, Massimo
影响因子:
7
作者:
Becher B;Segal BM
通讯作者:
Segal BM
影响因子:
9.3
作者:
Alboni S;Cervia D;Sugama S;Conti B
通讯作者:
Conti B
影响因子:
4.4
作者:
Calabrese, V;Scapagnini, G;Stella, AMG
通讯作者:
Stella, AMG